Praeventix LLC
Advertisement
Praeventix LLC is an early-stage biopharmaceutical company based in Exton, PA, dedicated to developing novel serotonergic therapeutics aimed at treating serotonergic-driven disorders, including chronic pruritus and inflammatory bowel disease (IBD). Founded by Dr. Douglas Pippin, the company is focused on its lead candidate, PRA523, a potential first-in-class neuromodulatory therapy targeting the 5HT7 receptor.
With a mission to enhance the quality of life for individuals suffering from these conditions, Praeventix is committed to advancing its innovative pipeline through discovery research and early clinical development. The company's leadership team brings extensive experience in drug development and organizational growth, positioning Praeventix to make significant contributions to the field of biopharmaceuticals.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement